Drug · DIN 02454343
PRAXBIND
5 G PER DOSE (2 X 2.5 G/50 ML)
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 24, 2016; first marketed May 24, 2016.
- Drug Identification Number (DIN)
- 02454343
- Company (DIN owner)
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Idarucizimab V03AB37
- Class
- Human
- Record last updated
- September 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| IDARUCIZUMAB | 50 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 29, 2016: NOC 18036New Drug Submission (NDS)